Subsequently, Huang et al. found that two potential FTO inhibitors, FB23 and FB23-2, could bind to FTO and discriminatingly inhibit the activity of FTO m6A demethylase, suppress proliferation and promote the apoptosis of human AML cells [33]. This evidence concerns the gene FTO and acute myeloid leukemia.